In the article titled "New and Emerging Therapies for Osteoporosis" [1] , there was an error regarding the FRAX5 tool, which should be clarified as follows.
The article notes: "The WHO has also developed a fracture risk assessment tool (FRAX) to estimate the 10-year probability of major osteoporotic fracture (clinical spine, hip, proximal humerus, and distal forearm) and hip fracture, using clinical risk factors for fracture and femoral neck bone mineral density (BMD), if available." However, the World Health Organization (WHO) did not develop, test, or endorse the FRAX tool or its recommendations [2] . The metabolic bone disease unit at the University of Sheffield that developed FRAX was a WHO Collaborating Centre from 1991 to 2010, but treatment guidelines must undergo a formal process before they can be endorsed by the WHO.
